Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain

Author： Miller Kate   Yarlas Aaron   Wen Warren   Dain Bradley   Lynch Shau Yu   Brennan Michael J   Ripa Steven R  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.3, 2013-02, pp. : 269-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fentanyl transdermal system vs oxycodone for chronic pain

By  

Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Chronic Pain Severity in Opioid-Dependent Patients

By Potter Jennifer   Shiffman Sara   Weiss Roger  

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 1, 2008-01 ,pp. : 101-107

Informa Healthcare

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite

A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain

By Ripa Steven R   McCarberg Bill H   Munera Catherine   Wen Warren   Landau Craig J  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1229-1241

Informa Healthcare

Access to resources Recommend Favorite